U.S. Markets open in 6 hrs 39 mins

Read This Before Selling Orthofix Medical Inc. (NASDAQ:OFIX) Shares

Sean Barnes

We’ve lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. Unfortunately, there are also plenty of examples of share prices declining precipitously after insiders have sold shares. So we’ll take a look at whether insiders have been buying or selling shares in Orthofix Medical Inc. (NASDAQ:OFIX).

Do Insider Transactions Matter?

Most investors know that it is quite permissible for company leaders, such as directors of the board, to buy and sell stock on the market. However, most countries require that the company discloses such transactions to the market.

Insider transactions are not the most important thing when it comes to long-term investing. But equally, we would consider it foolish to ignore insider transactions altogether. For example, a Columbia University study found that ‘insiders are more likely to engage in open market purchases of their own company’s stock when the firm is about to reveal new agreements with customers and suppliers’.

View our latest analysis for Orthofix Medical

Want to help shape the future of investing tools and platforms? Take the survey and be part of one of the most advanced studies of stock market investors to date.

Orthofix Medical Insider Transactions Over The Last Year

In the last twelve months, the biggest single purchase by an insider was when Chairman Ronald Matricaria bought US$520k worth of shares at a price of US$51.97 per share. That means that an insider was happy to buy shares at above the current price. It’s very possible they regret the purchase, but it’s more likely they are bullish about the company. We generally consider it a positive if insiders have been buying on market, even above the current price. The only individual insider to buy over the last year was Ronald Matricaria.

The chart below shows insider transactions (by individuals) over the last year. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

NasdaqGS:OFIX Insider Trading January 23rd 19

For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.

Insiders at Orthofix Medical Have Sold Stock Recently

The last three months saw significant insider selling at Orthofix Medical. Specifically, Director Luke Faulstick ditched US$253k worth of shares in that time, and we didn’t record any purchases whatsoever. Overall this makes us a bit cautious, but it’s not the be all and end all.

Does Orthofix Medical Boast High Insider Ownership?

I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. It appears that Orthofix Medical insiders own 2.8% of the company, worth about US$27m. We’ve certainly seen higher levels of insider ownership elsewhere, but these holdings are enough to suggest alignment between insiders and the other shareholders.

What Might The Insider Transactions At Orthofix Medical Tell Us?

An insider sold stock recently, but they haven’t been buying. But we take heart from prior transactions. It’s good to see insiders are shareholders. So we’re happy enough to look past some selling. Therefore, you should should definitely take a look at this FREE report showing analyst forecasts for Orthofix Medical.

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.

To help readers see past the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price-sensitive company announcements.

The author is an independent contributor and at the time of publication had no position in the stocks mentioned. For errors that warrant correction please contact the editor at editorial-team@simplywallst.com.